CYP19A1 and neoplasm: ERβ immunoreactivity was predominantly detected in the nuclei of hepatocytes and tumor cells as illustrated in Figure 4A. In MLC cases examined, ERβ LI was significantly higher in high aromatase score cases (score 4–8) than low aromatase score cases (score 0–2) (Fig. 4C) (P < 0.011).